Sartorius Stedim Biotech S.A. (LON:0RG8)
162.46
+5.19 (3.30%)
At close: Apr 10, 2025
Sartorius Stedim Biotech Revenue
Sartorius Stedim Biotech had revenue of 744.60M EUR in the quarter ending March 31, 2025, with 11.65% growth. This brings the company's revenue in the last twelve months to 2.86B, up 5.21% year-over-year. In the year 2024, Sartorius Stedim Biotech had annual revenue of 2.78B with 0.16% growth.
Revenue (ttm)
2.86B EUR
Revenue Growth
+5.21%
P/S Ratio
7.01
Revenue / Employee
288.63K EUR
Employees
9,901
Market Cap
16.76B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.78B | 4.50M | 0.16% |
Dec 31, 2023 | 2.78B | -717.20M | -20.53% |
Dec 31, 2022 | 3.49B | 605.70M | 20.98% |
Dec 31, 2021 | 2.89B | 976.92M | 51.15% |
Dec 31, 2020 | 1.91B | 469.51M | 32.59% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
HSBC Holdings | 48.93B |
Shell | 227.10B |
Unilever | 50.25B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |
British American Tobacco p.l.c. | 25.87B |
Rolls-Royce Holdings | 18.91B |